K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratificationAndrew S. Levey, Antonio M. Gotto, Josef Coresh et al.|Data Archiving and Networked Services (DANS)|2002Cited by 11.7k
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated NephropathyJeffrey B. Kopp, Cheryl A. Winkler, Eric E. Simon et al.|Journal of the American Society of Nephrology|2011Cited by 856
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisJeffrey B. Kopp, Cheryl A. Winkler, Michael W. Smith et al.|Nature Genetics|2008Cited by 706
MYH9 is associated with nondiabetic end-stage renal disease in African AmericansW.H. Linda Kao, Rulan S. Parekh, Michael J. Klag et al.|Nature Genetics|2008Cited by 648
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceCharles R. Swanepoel, Martin Zeier, Mohamed G. Atta et al.|Kidney International|2018Cited by 244